Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
meningococcal groups a and c and haemophilus b conjugate vaccine
- Development stage
- Phase 3
- Lead developer
- GSK
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
A conjugate vaccine designed to prevent invasive disease caused by Neisseria meningitidis serogroups A and C and Haemophilus influenzae type b. This vaccine combines meningococcal A and C polysaccharide antigens with Haemophilus influenzae type b antigens, all conjugated to a carrier protein to enhance immune response.
- Brand names
- Meningococcal A+C & Hib Conjugate Vaccine
- Other names
- Hib-MenAC vaccineHaemophilus influenzae type b-Neisseria meningitidis serogroup A and C-tetanus toxoid conjugate vaccine
02
Targets
γδ TCR (T-cell receptor)BCR (Immunoglobulin G B Cell Receptor)
Beyond the preview
Go deeper on meningococcal groups a and c and haemophilus b conjugate vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on meningococcal groups a and c and haemophilus b conjugate vaccine.